From Volume to Value: ACOs and Value-based Care

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,450	310 Pages	Darwin Health	April, 2017	DWH15319554

Best Price Guarantee
Price	from $3,450
Length	310 Pages
Publisher	Darwin Health
Published Date	April, 2017
SKU	DWH15319554

From Volume to Value: ACOs and Value-based Care

The health care marketplace has always been dynamic, but with the rapid rise in alternative payment models in recent years, health care executives must understand the move from volume to value—and the opportunities that are arising from the evolving health care delivery marketplace.

From Volume to Value: ACOs and Value-based Care is a complete overhaul of our original ACO Outlook report first launched in 2014. In this extensive report, we provide key insights into the world of accountable care, bundled payments and other value-based health care delivery models. ACOs and Value-based Care is informed by primary research from November 2016 with Darwin's ACO Executive Panel, as well as trends gleaned from our earlier ACO leadership surveys.

ACOs and Value-based Care is packed with original research and insights you won't find anywhere else. See below for a detailed table of contents.

The report consists of a printed, wire-bound document plus a downloadable .pdf, 310 pages, including a 24-page executive summary and 89 figures and tables. Subscribers will receive periodic updates in .pdf format for one year from the date of purchase.

Purchasers of either a Department or Global Site License will receive a 90-minute, in-person Q&A with Darwin Health CEO John Marchica. Please contact service@darwinhealth.net for more information.

Executive Summary
Chapter 1: Introduction
Chapter 2: Value-based Care Models
1. Value-Based Care Defined
2. Medicare ACO Models: Pioneer Model; Medicare Shared Savings Program; Advance Payment ACO Model; ACO Investment Model; Next Generation ACO; Comprehensive ESRD Care (CEC) Model; Newest Medicare ACO Models; “Vermont receives federal approval for statewide all-payer ACO
3. Other Value-based Care Models: Medicaid ACOs; Commercial ACOs; Employer-led ACOs; Employer-driven bundles; Patient-Centered Medical Homes
4. Innovation Center Initiatives: National: Bundled Payments for Care Improvement (BPCI) Initiative; Comprehensive Primary Care Initiative (CPC); Community-based Care Transitions Program (CCTP); FQHC Advanced Primary Care Practice Demonstration; Independence at Home Demonstration; “Independence at Home: A Success Story”; Home Health Value-based Reimbursement Pilot; Nursing Home Value-Based Purchasing Demonstration
5. Innovation Center Models: State
6. Innovation Center Models: Local
7. Issue Brief: The Oncology Care Model
8. Issue Brief: The Cardiac Care Bundle
9. Issue Brief: Understanding MACRA: 10. Issue Brief: Value-based Contracting in Pharmaceuticals
Chapter 3: 2016 ACO Executive Survey
1. Research Focus
2. Methodology
3. ACO Characteristics
4. Results: A. 2017 Initiatives; B. Reducing Readmissions; C. Patient Data Management; D. Issues Affecting Cost and Quality; E. Relationships with Suppliers and Providers; F. Relationships with Pharmaceutical Companies
5. Summary
Chapter 4: Influential ACOs
1. Advocate Health
2. Arizona Care Network
3. Atrius Health
4. Baylor Scott&White Quality Alliance
5. Beacon Health LLC
6. Beth Israel Deaconess Care Organization
7. Carolinas HealthCare System (Triad Health Network)
8. Dartmouth-Hitchcock
9. Memorial Hermann: 10. Ochsner Accountable Care Network LLC; 11. Optimus Healthcare Partners; 12. Partners HealthCare; 13. Physician Organization of Michigan; 14. UCLA Health ACO
Chapter 5: Performance: A. Quality; Medicare ACO Quality Metrics; MSSP Average Quality Scores, 2013-2015; Pioneer Average Quality Scores, 2012-2015; Quality Metrics
1. Patient/Caregiver Experience
2. Preventive Medicine
3. Readmission Rates
4. SNF Admissions
5. Unplanned Admissions for Patients with Diabetes
6. Unplanned Admissions for Patients with Heart Failure
7. Unplanned Admissions for Patients with Multiple Chronic Conditions
8. COPD or Asthma Admissions
9. Heart Failure: 10. Meaningful Use; 11. Diabetes Composite; 12. Overall Quality; B. Financial Performance 2015; C. Aggregate Financial Performance 2015; D. Bundled Payments
Chapter 6: Implications for Suppliers
1. Pharmacy
2. Pharmaceuticals and Biotechnology
3. Medical Device Providers
4. Durable Medical Equipment
5. Home Health Care
6. Ambulatory Care
7. Long-term Care
8. Other Providers and Suppliers
Chapter 7: Market Outlook
1. Issues and Opportunities
2. Critical Success Factors: Conclusion; Appendices; A: Innovation Awards; B: Original list of Pioneer ACOs; C. Convening Organizations; D: BPCI Participants and Convener Definitions; E: Darwin Health ACO of the Year Awards; F: Initial ACO Executive Survey Results; Figures; Figure 1.1 U.S. Population Growth Projections, 2015-2050; Figure 1.2 Weekly Closing Share Price: Astra Zeneca, Pfizer, GlaxoSmithKline, Novartis and Amgen; Figure 2.1 MSSP home office locations; Figure 2.2 Advance Payment ACO locations; Figure 2.3 Medicare Shared Savings Program locations; Figure 2.4 Home Health VBR Pilot Outcomes and Process Measures; Figure 3.1 Panel Distribution by Title: C-level Group; Figure 3.2 Panel Distribution by Region; Figure 3.3 2017 Initiatives: Behavioral Health, Alzheimer’s and Dementia; Figure 3.4 Factor Importance in Reducing Readmissions; Figure 3.5 EHR Usage in Practice; Figure 3.6 ACO Executive Concerns; Figure 3.7 Issues Affecting Quality of Care; Figure 3.8 Issues Affecting Ability to Control Costs; Figure 3.9 Existing Relationships with Suppliers and Other Providers; Figure 3.10 Exploring Relationships with Suppliers and Other Providers; Figure 3.11 Has a Simple Contract in Place; Figure 3.12 Has a Risk-based Contract in Place; Figure 3.13 Provider/Supplier Contracting 2014-2016; Figure 4.1 Advocate Health Care Value-based Initiatives; Figure 4.2 Advocate Physician Partners Accountable Care Visual Scorecard; Figure 4.3 Dignity Health Value-based Initiatives; Figure 4.4 Arizona Care Network Visual Scorecard; Figure 4.5 Atrius Health Value-based Initiatives; Figure 4.6 Atrius Health Pioneer ACO Visual Scorecard; Figure 4.7 Baylor Scott&White Value-based Initiatives; Figure 4.8 Baylor Scott&White MSSP Visual Scorecard; Figure 4.9 Beacon Health Value-based Initiatives; Figure 4.10 Beth Israel Deaconess Value-based Initiatives; Figure 4.11 Beth Israel Deaconess Pioneer ACO Visual Scorecard; Figure 4.12 Carolinas HealthCare System Value-based Initiatives; Figure 4.13 Triad HealthCare Network MSSP Visual Scorecard; Figure 4.14 Dartmouth-Hitchcock Value-based Initiatives; Figure 4.15 Dartmouth-Hitchcock Pioneer ACO Visual Scorecard; Figure 4.16 Memorial Hermann Value-based Initiatives; Figure 4.17 Memorial Hermann MSSP ACO Visual Scorecard; Figure 4.18 Ochsner Health System Value-based Initiatives; Figure 4.19 Ochsner Accountable Care Network MSSP Visual Scorecard; Figure 4.20 Optimus Healthcare Partners Value-based Initiatives; Figure 4.21 Optimus Healthcare Partners MSSP Visual Scorecard; Figure 4.22 Partners HealthCare Value-based Initiatives; Figure 4.23 Partners HealthCare Pioneer ACO Visual Scorecard; Figure 4.24 Physician’s Organization of Michigan Value-based Initiatives; Figure 4.25 POM ACO MSSP Visual Scorecard; Figure 4.26 UCLA Value-based Initiatives; Figure 4.27 UCLA Faculty Practice Group MSSP Visual Scorecard; Figure 7.1 Big Data in Health Care; Figure 7.2 Factors Affecting Readmission; Figure 7.3 The Patient-Reported Outcome-Quality of Life Tool; Figure 7.4 Prevalence of heart disease, hypertension, stroke and cancer among adults aged 65 and over; Figure 7.5 2016 Executive Survey—EHR Usage; Tables; Table 2.1 Pioneer ACOs; Table 2.2 Pioneer ACOs: What happened to the dropouts?; Table 2.3 Payment Characteristics; Table 2.4 MSSPs By Region; Table 2.5 Advance Payment ACOs; Table 2.6 Investment Model ACOs; Table 2.7 Next Generation ACOs; Table 2.8 Pioneer vs. Next Generation ACO; Table 2.9 ESCO Participating Providers; Table 2.10 Medicaid Program Structure; Table 2.11 Top Convening Organizations; Table 3.1 Sample Characteristics; Table 3.2 Factor Importance in Reducing Readmissions; Table 3.3 Simple Contracting, 2014-2016; Table 3.4 Risk-based Contracting, 2014-2016; Table 3.5 ACO Contracting by ACO Model; Table 5.1 Medicare ACO Quality Metrics; Table 5.2 MSSP Average Quality Scores, 2013-2015; Table 5.3 Pioneer Average Quality Scores, 2012-2015; Table 5.4 Top Decile MSSP ACOs, Patient/Caregiver Experience; Table 5.5 Top Decile MSSP ACOs, Preventive Medicine; Table 5.6 Top Decile MSSP ACOs, Readmission Rates; Table 5.7 Top Decile MSSP ACOs, SNF Admissions; Table 5.8 Top Decile MSSP ACOs, Unplanned Admissions for Patients with Diabetes; Table 5.9 Top Decile MSSP ACOs, Unplanned Admissions for Patients with Heart Failure; Table 5.10 Top Decile MSSP ACOs, Unplanned Admissions for Patients with Multiple Chronic Conditions; Table 5.11 Top Decile MSSP ACOs, COPD or Asthma Admissions; Table 5.12 Top Decile MSSP ACOs, Heart Failure; Table 5.13 All ACOs with 100 percent Meaningful Use Attestation; Table 5.14 Top Decile MSSP ACOs, Diabetes Composite; Table 5.15 Top Decile MSSP ACOs, Overall Quality; Table 5.16 MSSP ACOs with the Highest Earned Shared Savings; Table 5.17 MSSP ACOs with the Largest Losses; Table 5.18 MSSP ACO Financial Performance, 2013-2015; Table 5.19 MSSP ACO Performance per Beneficiary; Table 5.20 Pioneer ACO Financial Performance, 2013-2015; Table 5.21 Pioneer ACO Performance per Beneficiary; Table 7.1 Telehealth Private Insurance Coverage; Table 7.2 Cost Comparison of Medical Procedures, 2006 (U.S. dollars)